STATE STREET CORP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$13,815,973
-19.1%
2,535,041
-0.4%
0.00%0.0%
Q2 2023$17,074,454
-24.7%
2,544,628
-0.9%
0.00%0.0%
Q1 2023$22,671,747
-40.7%
2,568,042
-48.7%
0.00%0.0%
Q4 2022$38,222,202
+116.8%
5,002,906
+102.0%
0.00%0.0%
Q3 2022$17,632,000
-6.8%
2,476,435
+5.9%
0.00%0.0%
Q2 2022$18,926,000
-27.3%
2,339,384
+24.8%
0.00%0.0%
Q1 2022$26,018,000
-43.1%
1,874,471
+14.9%
0.00%
-50.0%
Q4 2021$45,763,000
-11.8%
1,630,890
+6.9%
0.00%
-33.3%
Q3 2021$51,861,000
-11.1%
1,525,758
+6.9%
0.00%0.0%
Q2 2021$58,304,000
+51.9%
1,426,921
+49.6%
0.00%
+50.0%
Q1 2021$38,390,000
-32.0%
953,543
-0.2%
0.00%
-33.3%
Q4 2020$56,489,000
+26.2%
955,334
+3.8%
0.00%0.0%
Q3 2020$44,767,000
+13.8%
920,567
+13.2%
0.00%0.0%
Q2 2020$39,350,000
+98.4%
813,357
+13.9%
0.00%
+50.0%
Q1 2020$19,832,000
+155.1%
713,896
+174.7%
0.00%
+100.0%
Q4 2019$7,775,000
+70.4%
259,853
+76.0%
0.00%
Q3 2019$4,562,000147,6310.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q3 2023
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders